ChatAbout Prof. Dr. Elke Jaeger
- Prof. Dr. Elke Jaeger is a Hematologist-Oncologist in Germany with experience of over 35+ years.
- She is the Chair of Interdisciplinary Oncology at Goethe University Frankfurt and is a member of the Academy of Cancer Immunology, USA, and an adjunct Professor at Roswell Park Cancer Center, USA.
- She received her medical education from the universities of Mainz, Würzburg, Cologne from 1979 to 1985, and later did her Ph.D. in internal medicine from the Bavarian Julius Maximilian University, Würzburg in 1986.
- She has run numerous Phase I clinical trials in the field of experimental oncology medicines and managed a variety of clinical Phase II/III trials for pharmaceutical treatments of various malignant diseases.
- She also has trained students in the practical year at the Johann Wolfgang Goethe University, Frankfurt.
- Her areas of interest are the treatment of leukemia and lymphoma, Radiochemotherapy, stem cell transplant (autologous, allogenic & umbilical cord blood transplant), Antibody Therapy, Immunotherapy, anemia, etc.
- Dr. Jaeger has presented many papers at diverse conferences held nationally and internationally.
Hospital
Nordwest Hospital, Frankfurt
Hospital Location
Frankfurt, Germany 
LocationSpecial Interest
Bronchial carcinoma Malignant lymphoma Plasmocytoma Sarcoma Antibody Therapy Immunotherapy Targeted Therapy Cytokine Therapy Puncture of Ascites and Pleura
Work Experience of Prof. Dr. Elke Jaeger
Associate Consultant, Department of Pathology at Johannes Gutenberg University, Mainz
Prof. Dr. Elke Jaeger's
- Graduation, 1979, Universities of Mainz, Würzburg, Cologne
- Post Graduation, 1986, Bavarian Julius Maximilian University, Würzburg
- Knuth, A., Bernhard, H., Jäger, E., Wolfel, T., Karbach, J., Jaggle, C., Strittmatter, W., Meyer zum Buschenfelde, K.H. Induction of tumour cell lysis by a bispecific antibody recognizing epidermal growth factor receptor (EGFR) and CD3. Eur J Cancer 30A:1103-7, 1994.
- Bergmann, L., Karakas, T., Lautenschlager, G., Jäger, E., Knuth, A., Mitrou, P.S., Hoelzer, D. Vincristine, doxorubicin, cyclophosphamide, prednisone, and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma--a multicenter phase II study. Ann Oncol 6:1019-24, 1995.
- Bernhard, H., Jäger, E., Bernhard, G., Heike, M., Klein, O., Riemann, J.F., Meyer zum Buschenfelde, K.H., Dippold, W., Knuth, A. Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial. Br J Cancer 71:102-5, 1995.
- Jäger, E., Bernhard, H., Klein, O., Wachter, B., Theiss, F., Dippold, W., Meyer zum Buschenfelde, K.H., Knuth, A. Combination 5-fluorouracil (FU), folinic acid (FA), and alpha-interferon 2B in advanced gastric cancer: results of a phase II trial. Ann Oncol 6:153-6, 1995.
- Jäger, E., Klein, O., Wächter, B., Muller, B., Braun, U., Knuth, A. Second-line treatment with high-dose 5- fluorouracil and folinic acid in advanced colorectal cancer refractory to standard-dose 5-fluorouracil treatment. Oncology 52:470-3, 1995.
- Jäger, E., Klein, O., Wächter, B., Muller, B., Braun, U., Knuth, A. High dose 5-fluorouracil (5-FU) and folinic acid in advanced colorectal cancer resistant to standard dose 5-FU treatment: results of a phase II study. Eur J Cancer 31A:1717, 1995.
Wondering where to start?
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
Doctor Similar to Prof. Dr. Elke Jaeger in Frankfurt
Prof. Dr. Eckhart Weidmann
Book Appointment Contact Doctor Hematologist
Chief
Fellowship,Graduation
Frankfurt, Germany
34 years of experience
